ArticleBMJ open2025
Protocol for a comprehensive analysis of hepatitis C risk factors among the Rohingya population in camp settings in Cox's Bazar: a mixed-method study.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe hepatitis C virus (HCV)-a communicable disease of global health concerns-affects approximately 20% of the Rohingya refugee population in Cox's Bazar, Bangladesh, which is higher than that observed in its endemic country and the host population. This study will assess socio-demographic, medical, traditional and behavioural factors contributing to HCV risk among the Rohingya refugee population to provide the basis for future prevention efforts.
methodsA mixed-method study using a sequential explanatory design, combining qualitative and quantitative approaches, will be employed. For phase one, a case-control study of 900 HCV-positive cases and 900 matched HCV-negative controls will be conducted to determine associations with risk factors through semi-structured questionnaires. For phase two, focus group discussions (n=12) and key informant interviews (n=50) with caregivers, healthcare providers and community members will help explain and expand on the quantitative findings. Analyses will include logistic regression (quantitative) and thematic analysis (qualitative). EXPECTED OUTCOMES: The study aims to identify key risk factors, including unsafe medical practices, traditional procedures, personal hygiene behaviours and sexual practices, and assess their association with HCV seropositivity. Findings will support recommendations for evidence-based prevention as well as policy and community initiatives to reduce HCV transmission among refugee populations. ETHICS AND DISSEMINATION: Ethical approval has been obtained from Cox's Bazar Medical College Hospital (Approval Ref: CoXMC/2024/019). Findings will be disseminated through peer-reviewed publications and stakeholder workshops to inform policy and programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.